Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Clasificación en acciones #39915
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Precio por acción
$0.00366968
Última sincronización: 2024-07-12
Capitalización bursátil
$299.46K
Cambio (1 día)
-66.77%
Cambio (1 año)
0.00%
País
CA
Comercio Biocure Technology Inc. (CURE)

Categoría

Precio CURE con Capital del mercado a B
Biocure Technology Inc. Biocure Technology Inc.
CURE
$0.00366968
Capitalización de mercado de Biocure Technology Inc.(CURE)
Capitalización bursátil: $299.46K
A fecha de August 2026, Biocure Technology Inc. tiene una capitalización de mercado de $299.46K. Esto convierte a Biocure Technology Inc. en la 39915th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Biocure Technology Inc. desde 2009 hasta 2026
CURE en comparación con los más populares 5 títulos stocks
Precio por CURE Activo B Capital del mercado en B Resultados
Biocure Technology Inc. Biocure Technology Inc.
$67,025.69 $299.46K
$5.470T +1,826,470,084.21%
Biocure Technology Inc. Biocure Technology Inc.
$54,741.10 $299.46K
$4.467T +1,491,711,392.75%
Biocure Technology Inc. Biocure Technology Inc.
$51,154.44 $299.46K
$4.174T +1,393,973,677.14%
Biocure Technology Inc. Biocure Technology Inc.
$45,342.08 $299.46K
$3.700T +1,235,585,274.74%
Biocure Technology Inc. Biocure Technology Inc.
$34,978.15 $299.46K
$2.854T +953,164,874.40%